Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinianjin is a traditional Chinese medicine (TCM) formula with over 400 years of history in Chinese pediatric practice. It is a multi-herb preparation composed of cinnabar (a mercury-containing mineral, approximately 5.66% w/w), rhubarb, stir-fried morning glory seeds (Pharbitidis Semen), areca nut (Arecae Semen), and ginseng. Yinianjin is primarily used in pediatric patients (aged 0 to 6 years) to promote digestion, eliminate phlegm, and relieve constipation. A transdermal patch formulation of the formula, known as YNJ patch (YNJP), has been developed to mitigate the mercury exposure and low bioavailability associated with oral administration. YNJP has been shown to enhance intestinal motility and propulsion by regulating the expression of mucin 2 (MUC2), aquaporin 3 (AQP3), and tight junction protein 1 (TJP1), while promoting the release of endocrine homeostatic transmitters and Lactobacilli-mediated short-chain fatty acids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yinianjin.
Work on yinianjin? Claim this page to correct or add information. Claim this page